Cytosorbents (NASDAQ:CTSO – Get Free Report)‘s stock had its “buy” rating restated by D. Boral Capital in a research report issued on Friday,Benzinga reports. They currently have a $10.00 price ...

Research analysts at StockNews.com assumed coverage on shares of Cytosorbents (NASDAQ:CTSO – Get Free Report) in a research note issued on Sunday. The brokerage set a “hold” rating on the medical ...

Get Real-Time News and Alerts for Your Portfolio CytoSorbents Corporation CTSO shares are trading lower on Friday after the company reported fourth-quarter 2024 preliminary results. The company ...

PRINCETON, N.J. - CytoSorbents Corporation (NASDAQ: CTSO), a medical device company specializing in blood purification with a current market capitalization of $50.31 million, announced preliminary ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

If you subscribe to the Lefsetz Letter—the email bulletin from music business guru Bob Lefsetz—you will find yourself waiting impatiently, as I do, for its irregular arrival in your inbox. The ...

CytoSorbents (CTSO) announces the commencement of its Rights Offering, previously detailed in our December 9, 2024 announcement press release. Stockholders and certain Warrantholders of record on ...

The Mets were busy in the weeks leading up to their historic, 15-year agreement with Juan Soto, but it had been oddly quiet in Queens since Soto’s momentous introductory news conference on Dec. 12.

Dear Eric: My husband and I have been married for more than 30 years and enjoy each other’s company. As with other couples, after many years there are certain things that we do that get on each ...